Table 6 Associations between quartiles of arsenic exposure and odds of self-reported symptoms during pregnancy in a subpopulation of women who did not report taking prescription or herbal medication during pregnancy (N = 1,166)

2.84 (1.98–4.07)

2.33 (1.56–3.50)

0.79 (0.50–1.27)

0.79 (0.47–1.31)

2.17 (1.54–3.06)

1.86 (1.27–2.71)

2.49 (1.77–3.51)

1.80 (1.23–2.62)

1.14 (0.81–1.62)

1.09 (0.74–1.61)

2.35 (1.66, 3.34)

2.06 (1.39–3.05)

0.96 (0.61–1.51)

0.91 (0.55–1.51)

1.78 (1.27–2.51)

1.55 (1.06–2.27)

1.96 (1.39–2.76)

1.45 (0.99–2.13)

0.97 (0.68–1.38)

0.91 (0.61–1.35)

0.60 (0.44–0.83)

0.64 (0.45–0.92)

1.30 (0.86–1.98)

1.47 (0.94–2.32)

0.86 (0.61–1.22)

0.94 (0.64–1.37)

0.55 (0.37–0.80)

0.55 (0.37–0.83)

0.72 (0.50–1.02)

0.79 (0.54–1.16)

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

1.0 Ref

<0.0001

<0.0001

0.13

0.39

<0.0001

0.0007

<0.0001

<0.0001

0.04

0.37